Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Pyridoxine-dependent epilepsy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Pyridoxine-dependent epilepsy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Sulfite oxidase deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Sulfite oxidase deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Molybdenum cofactor deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Molybdenum cofactor deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
N-acetylglutamate synthase deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 N-acetylglutamate synthase deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Hyperinsulinism-hyperammonemia syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Hyperinsulinism-hyperammonemia syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Citrullinemia type 1 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Citrullinemia type 1 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Hereditary orotic aciduria Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Hereditary orotic aciduria strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Lesch-Nyhan syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Lesch-Nyhan syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Trimethylaminuria Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Trimethylaminuria indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Tyrosinemia type 2 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Tyrosinemia type 2 indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
3-hydroxy-3-methylglutaryl-CoA lyase deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 3-hydroxy-3-methylglutaryl-CoA lyase deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Cobalamin C deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Cobalamin C deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.